Literature DB >> 26026611

Cadmium-induced cell death of basal forebrain cholinergic neurons mediated by muscarinic M1 receptor blockade, increase in GSK-3β enzyme, β-amyloid and tau protein levels.

Javier Del Pino1, Gabriela Zeballos2, María José Anadón2, Paula Moyano2, María Jesús Díaz3, José Manuel García2, María Teresa Frejo3.   

Abstract

Cadmium is a neurotoxic compound which induces cognitive alterations similar to those produced by Alzheimer's disease (AD). However, the mechanism through which cadmium induces this effect remains unknown. In this regard, we described in a previous work that cadmium blocks cholinergic transmission and induces a more pronounced cell death on cholinergic neurons from basal forebrain which is partially mediated by AChE overexpression. Degeneration of basal forebrain cholinergic neurons, as happens in AD, results in memory deficits attributable to the loss of cholinergic modulation of hippocampal synaptic circuits. Moreover, cadmium has been described to activate GSK-3β, induce Aβ protein production and tau filament formation, which have been related to a selective loss of basal forebrain cholinergic neurons and development of AD. The present study is aimed at researching the mechanisms of cell death induced by cadmium on basal forebrain cholinergic neurons. For this purpose, we evaluated, in SN56 cholinergic mourine septal cell line from basal forebrain region, the cadmium toxic effects on neuronal viability through muscarinic M1 receptor, AChE splice variants, GSK-3β enzyme, Aβ and tau proteins. This study proves that cadmium induces cell death on cholinergic neurons through blockade of M1 receptor, overexpression of AChE-S and GSK-3β, down-regulation of AChE-R and increase in Aβ and total and phosphorylated tau protein levels. Our present results provide new understanding of the mechanisms contributing to the harmful effects of cadmium on cholinergic neurons and suggest that cadmium could mediate these mechanisms by M1R blockade through AChE splices altered expression.

Entities:  

Keywords:  Acetylcholine esterase-R; Acetylcholine esterase-S; Aβ; Cadmium; GSK-3β; Muscarinic receptor M1; SN56 cells septal basal forebrain cholinergic neurons; Tau

Mesh:

Substances:

Year:  2015        PMID: 26026611     DOI: 10.1007/s00204-015-1540-7

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  16 in total

1.  Association Between Anticholinergic Medication Use and Cognition, Brain Metabolism, and Brain Atrophy in Cognitively Normal Older Adults.

Authors:  Shannon L Risacher; Brenna C McDonald; Eileen F Tallman; John D West; Martin R Farlow; Fredrick W Unverzagt; Sujuan Gao; Malaz Boustani; Paul K Crane; Ronald C Petersen; Clifford R Jack; William J Jagust; Paul S Aisen; Michael W Weiner; Andrew J Saykin
Journal:  JAMA Neurol       Date:  2016-06-01       Impact factor: 18.302

Review 2.  Molecular Mechanisms of Metal Toxicity in the Pathogenesis of Alzheimer's Disease.

Authors:  Md Tanvir Kabir; Md Sahab Uddin; Sonia Zaman; Yesmin Begum; Ghulam Md Ashraf; May N Bin-Jumah; Simona G Bungau; Shaker A Mousa; Mohamed M Abdel-Daim
Journal:  Mol Neurobiol       Date:  2020-09-05       Impact factor: 5.590

3.  Exposure to Strong Anticholinergic Medications and Dementia-Related Neuropathology in a Community-Based Autopsy Cohort.

Authors:  Shelly L Gray; Melissa L Anderson; Joseph T Hanlon; Sascha Dublin; Rod L Walker; Rebecca A Hubbard; Onchee Yu; Thomas J Montine; Paul K Crane; Josh A Sonnen; C Dirk Keene; Eric B Larson
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

4.  The Protection of Zinc against Acute Cadmium Exposure: A Morphological and Molecular Study on a BBB In Vitro Model.

Authors:  Jacopo J V Branca; Donatello Carrino; Ferdinando Paternostro; Gabriele Morucci; Claudia Fiorillo; Claudio Nicoletti; Massimo Gulisano; Carla Ghelardini; Lorenzo Di Cesare Mannelli; Matteo Becatti; Alessandra Pacini
Journal:  Cells       Date:  2022-05-15       Impact factor: 7.666

5.  Cadmium and Alzheimer's disease mortality in U.S. adults: Updated evidence with a urinary biomarker and extended follow-up time.

Authors:  Qing Peng; Kelly M Bakulski; Bin Nan; Sung Kyun Park
Journal:  Environ Res       Date:  2017-05-13       Impact factor: 6.498

6.  Anticholinergics Influence Transition from Normal Cognition to Mild Cognitive Impairment in Older Adults in Primary Care.

Authors:  Noll L Campbell; Kathleen A Lane; Sujuan Gao; Malaz A Boustani; Fred Unverzagt
Journal:  Pharmacotherapy       Date:  2018-04-25       Impact factor: 4.705

Review 7.  Heavy Metals Exposure and Alzheimer's Disease and Related Dementias.

Authors:  Kelly M Bakulski; Young Ah Seo; Ruby C Hickman; Daniel Brandt; Harita S Vadari; Howard Hu; Sung Kyun Park
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

Review 8.  Metal Toxicity Links to Alzheimer's Disease and Neuroinflammation.

Authors:  Tee Jong Huat; Judith Camats-Perna; Estella A Newcombe; Nicholas Valmas; Masashi Kitazawa; Rodrigo Medeiros
Journal:  J Mol Biol       Date:  2019-01-18       Impact factor: 5.469

9.  Chromium picolinate attenuates cognitive deficit in ICV-STZ rat paradigm of sporadic Alzheimer's-like dementia via targeting neuroinflammatory and IRS-1/PI3K/AKT/GSK-3β pathway.

Authors:  Ansab Akhtar; Jatinder Dhaliwal; Priyanka Saroj; Ankit Uniyal; Mahendra Bishnoi; Sangeeta Pilkhwal Sah
Journal:  Inflammopharmacology       Date:  2020-01-03       Impact factor: 4.473

Review 10.  Metal Ion Effects on Aβ and Tau Aggregation.

Authors:  Anne Claire Kim; Sungsu Lim; Yun Kyung Kim
Journal:  Int J Mol Sci       Date:  2018-01-02       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.